More importantly, we found that miR‐138 also played major roles in NSCLC EMT by directly targeting SEMA4C and GIT1, which suggests that miR‐138 might be a multifunctional regulator in NSCLC. Here, SEMA4C is linked to non-small cell lung carcinoma.